What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis? ; volume:18 ; number:1 ; day:1 ; month:12 ; year:2016 ; pages:1-10 ; date:12.2016
Arthritis Research & Therapy ; 18, Heft 1 (1.12.2016), 1-10, 12.2016
- Urheber
-
Humphreys, Jenny
- Beteiligte Personen und Organisationen
-
Hyrich, Kimme
Symmons, Deborah
SpringerLink (Online service)
- DOI
-
10.1186/s13075-016-1176-x
- URN
-
urn:nbn:de:1111-201612208526
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Humphreys, Jenny
- Hyrich, Kimme
- Symmons, Deborah
- SpringerLink (Online service)
Ähnliche Objekte (12)
Co-morbidities of vertiginous diseases
ARV regimen choice and co-morbidities
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Age-related co-morbidities in people living with HIV
0231. Growing old with HIV — dealing with co-morbidities
Pertussis in Individuals with Co-morbidities: A Systematic Review
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study
Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice
Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database
PReS13-SPK-1129: Biologic therapies in SLE
Cardiovascular and musculoskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency
Co-morbidities of vertiginous diseases
ARV regimen choice and co-morbidities
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Age-related co-morbidities in people living with HIV
0231. Growing old with HIV — dealing with co-morbidities
Pertussis in Individuals with Co-morbidities: A Systematic Review
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study
Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice
Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database
PReS13-SPK-1129: Biologic therapies in SLE
Cardiovascular and musculoskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency
Co-morbidities of vertiginous diseases
ARV regimen choice and co-morbidities
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Age-related co-morbidities in people living with HIV
0231. Growing old with HIV — dealing with co-morbidities
Pertussis in Individuals with Co-morbidities: A Systematic Review
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study
Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice
Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database
PReS13-SPK-1129: Biologic therapies in SLE